ArticleFrontiers in pharmacology2022

Quantitative effects of sodium-glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients.

Dong-Dong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.